Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with moderate to severe primary shoulder osteoarthritis (stage II or higher, based on a classification system called Samilson-Prieto), confirmed by both physical examination and imaging.
- People aged between 20 and 90 years.
- People with osteoarthritis in both shoulders may be considered, but only one shoulder can be included in the study — the participant would choose which side.
- People whose shoulder pain rates at least 4 out of 10 on a pain scale.
- People who have the mental ability to read and complete questionnaires.
- People who can read and understand French or English.
Who may not be able to join:
- People who have a complete tear through the rotator cuff (a group of tendons in the shoulder), as shown on an MRI scan.
- People who have previously had reconstructive surgery on the shoulder being studied.
- People who are pregnant.
- People who have had a cortisone injection in the shoulder within the past 6 months.
- People who have had a platelet-rich plasma (PRP) or hyaluronic acid injection in the shoulder within the past 12 months.
- People diagnosed with avascular necrosis (a condition where bone tissue dies due to lack of blood supply).
- People with a condition affecting the shoulder joint, such as a systemic inflammatory disease, a history of joint infection, or bone death in the joint.
- People with a suspected or confirmed active infection near the shoulder.
- People with a known or suspected tumour or cancer spread near the shoulder.
- People who have had a significant shoulder injury within the past 3 months.
- People with significant cognitive impairment or insufficient language skills to complete the study questionnaires.
- People with any other serious medical condition that the trial site determines would prevent safe participation or make a cortisone injection unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Patrice Tétreault, MD FRCSC, CHUM
Phone: 5148908000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in VAS score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.